Results 31 to 40 of about 50,432 (266)

The stenting strategy of drug-eluting stents for coronary artery disease in patients on dialysis

SAGE Open Medicine, 2014
Background: Reports regarding the relationship between the length and diameter of implanted drug-eluting stents and clinical and angiographic outcomes in dialysis patients are limited.
Hiroshi Fujita, Kenya Nasu, Mitsuyasu Terashima, Tsuyoshi Ito, Tomomitsu Tani, Takahiko Suzuki, Nobuyuki Ohte   +6 more
doaj   +1 more source

Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis. [PDF]

, 2014
peer reviewedOBJECTIVE: To investigate whether revascularisation improves prognosis compared with medical treatment among patients with stable coronary artery disease.
Alfonso, Fernando, Clemmensen, Peter M, Collet, Jean-Philippe, Cremer, Jochen, da Costa, Bruno R, daCosta, Bruno R, Di Nisio, Marcello, Falk, Volkmar, Filippatos, Gerasimos, Hamm, Christian, Head, Stuart, Juni, Peter, Jüni, Peter, Kappetein, Arie Pieter, Kastrati, Adnan, Knuuti, Juhani, Kolh, Philippe, Landmesser, Ulf, Laufer, Günther, Maione, Ausilia, Neumann, Franz-Joseph, Richter, Dimitri, Rutjes, Anne Wilhelmina, Schauerte, Patrick, Siletta, Maria G, Silletta, Maria G, Sousa Uva, Miguel, Stefanini, Giulio G, Stortecky, Stefan, Taggart, David P, Torracca, Lucia, Valgimigli, Marco, Wijns, William, Windecker, Stephan, Witkowski, Adam   +34 more
core   +3 more sources

The future of drug-eluting stents

Pharmacological Research, 2008
This review aims to provide a glimpse into the future of drug-eluting stents (DES). Since their arrival in 2002, DES have transformed the practice of interventional cardiology by drastically reducing restenosis and the need for repeat revascularization.
Joost Daemen, Neville Kukreja, Patrick W. Serruys, Yoshinobu Onuma   +3 more
openaire   +2 more sources

Drug Distribution and Stent Retention of Drug Eluting Stents [PDF]

, 2008
In this paper the examinations of drug eluting coronary stents are shown, such as the morphology of the coatings before expansion, drug distribution, the methodology and the value of stent retention.
Balázs, T., Bognár, Eszter, Dobránszky, János, Ring, Gy.   +3 more
core  

Novel Drug‐Testing Platform for Vascular Injury‐induced Intimal Hyperplasia Using a Microphysiological System

Advanced Healthcare Materials, EarlyView.
This study develops a 3D vascular injury model using a microphysiological system that mimics key features of intimal hyperplasia. Antiproliferative drugs reduced VSMC proliferation but worsened endothelialdenudation. A combination of diphenyleneiodonium and quercetin effectively reduced proliferation and migration of VSMC and inflammation while ...
Ungsig Nam, HyeMi Kim, Jeong Ah Kim, Ki‐Hwan Nam, Kye‐Sung Lee, Hwan Hur, Jessie S. Jeon, Ji Yong Bae   +7 more
wiley   +1 more source

Does the use of paclitaxel or rapamycin-eluting stent decrease further need for coronary-artery bypass grafting when compared with bare-metal stent?

São Paulo Medical Journal
CONTEXT AND OBJECTIVE: The safety and efficacy of drug-eluting stents reduce the need for surgical revascularization. The objective of the present study was to investigate whether paclitaxel or rapamycin-eluting stent are effective in avoiding the need ...
Hernani Pinto de Lemos Júnior, Álvaro Nagib Atallah   +1 more
doaj   +1 more source

Very Late Stent Thrombosis 42 Months after Implantation of Sirolimus-Eluting Stent and Discontinuation of Antiplatelet Therapy

Case Reports in Medicine, 2009
Although safety profiles of sirolimus-eluting stents do not seem to differ in short-to-medium term from those of bare-metal stents, late stent thrombosis after deployment of drug-eluting stents has emerged as a potential safety concern in the era of high-
Dirk Sibbing, Karl-Ludwig Laugwitz, Lorenz Bott-Flügel, Jürgen Pache   +3 more
doaj   +1 more source

Drug-eluting stents: current issues [PDF]

, 2005
Early stent thrombosis occurs in about 1% to 1.5% of patients with drug-eluting stents, very similar to the rate with bare-metal stents. Late stent thrombosis is more of a concern with drug-eluting stents, with an incidence of at least 0.35%.
Ong, A.T.L. (Andrew), Serruys, P.W.J.C. (Patrick)   +1 more
core   +1 more source

Cell Calcification Models and Their Implications for Medicine and Biomaterial Research

Advanced Healthcare Materials, EarlyView.
Calcification, is the process by which the tissues containing minerals are formed, occurring during normal physiological processes, or in pathological conditions. Here, it is aimed to give a comprehensive overview of the range of cell models available, and the approaches taken by these models, highlighting when and how methodological divergences arise,
Luke Hunter, Caterina Vanelli Coralli, Robert Dzhanaev, Aaron Morgan, Willi Jahnen‐Dechent, Sergio Bertazzo   +5 more
wiley   +1 more source

Efficacy and Safety of Drug-Eluting Stents in the Real World: 8-Year Follow-Up

Arquivos Brasileiros de Cardiologia, 2014
Background: Drug-eluting stents have been used in daily practice since 2002, with the clear advantages of reducing the risk of target vessel revascularization and an impressive reduction in restenosis rate by 50%-70%.
Denise Oliveira Pellegrini, Vitor Osório Gomes, Ricardo Lasevitch, Luis Smidt, Marco Aurélio Azeredo, Priscila Ledur, Rodrigo Bodanese, Leonardo Sinnott, Emílio Moriguchi, Paulo Caramori   +9 more
doaj   +1 more source